# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
0, Journal, 0, 11, "Clin Ther .", "", "<http://ctro/data#Publication_103126> <http://ctro/data#hasJournal> \"Clin Ther .\"."
1, PublicationYear, 12, 16, "1998", "", "<http://ctro/data#Publication_103126> <http://ctro/data#hasPublicationYear> \"1998\"."
9, Title, 51, 181, "Comparison of the efficacy and safety of 2 % dorzolamide and 0 . 5 % betaxolol in the treatment of elevated intraocular pressure .", "", "<http://ctro/data#Publication_103126> <http://ctro/data#hasTitle> \"Comparison of the efficacy and safety of 2 % dorzolamide and 0 . 5 % betaxolol in the treatment of elevated intraocular pressure .\"."
5, DoseValue, 92, 93, "2", "", 
7, Percentage, 94, 95, "%", "", 
2, Dorzolamide, 96, 107, "dorzolamide", "", 
6, DoseValue, 112, 117, "0 . 5", "", 
8, Percentage, 118, 119, "%", "", 
3, Betaxolol, 120, 129, "betaxolol", "", 
4, IOP, 159, 179, "intraocular pressure", "", 
10, Dorzolamide, 182, 193, "Dorzolamide", "", 
11, Author, 219, 225, "Rusk C", "", "<http://ctro/data#Publication_103126> <http://ctro/data#hasAuthor> \"Rusk C\"."
12, Author, 234, 242, "Sharpe E", "", "<http://ctro/data#Publication_103126> <http://ctro/data#hasAuthor> \"Sharpe E\"."
13, Author, 245, 255, "Laurence J", "", "<http://ctro/data#Publication_103126> <http://ctro/data#hasAuthor> \"Laurence J\"."
14, Author, 258, 265, "Polis A", "", "<http://ctro/data#Publication_103126> <http://ctro/data#hasAuthor> \"Polis A\"."
15, Author, 268, 278, "Adamsons I", "", "<http://ctro/data#Publication_103126> <http://ctro/data#hasAuthor> \"Adamsons I\"."
106, USA, 365, 368, "USA", "", "<http://ctro/data#Population_103158> <http://ctro/data#hasCountry> <http://ctro/data#USA>."
17, Multicenter, 373, 384, "multicenter", "", "<http://ctro/data#ClinicalTrial_103137> <http://ctro/data#hasCTDesign> <http://ctro/data#Multicenter>."
108, Parallel, 387, 404, "parallel - design", "", "<http://ctro/data#ClinicalTrial_103137> <http://ctro/data#hasCTDesign> <http://ctro/data#Parallel>."
19, Randomized, 407, 417, "randomized", "", "<http://ctro/data#ClinicalTrial_103137> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
20, DoubleBlind, 420, 435, "double - masked", "", "<http://ctro/data#ClinicalTrial_103137> <http://ctro/data#hasCTDesign> <http://ctro/data#DoubleBlind>."
29, ObjectiveDescription, 459, 607, "compare the efficacy and safety of 2 % dorzolamide with those of 0 . 5 % betaxolol in the treatment of elevated intraocular pressure ( i . o . p ) .", "", "<http://ctro/data#ClinicalTrial_103137> <http://ctro/data#hasObjectiveDescription> \"compare the efficacy and safety of 2 % dorzolamide with those of 0 . 5 % betaxolol in the treatment of elevated intraocular pressure ( i . o . p ) .\"."
25, DoseValue, 494, 495, "2", "", 
27, Percentage, 496, 497, "%", "", 
21, Dorzolamide, 498, 509, "dorzolamide", "", 
26, DoseValue, 524, 529, "0 . 5", "", 
28, Percentage, 530, 531, "%", "", 
22, Betaxolol, 532, 541, "betaxolol", "", 
23, IOP, 571, 591, "intraocular pressure", "", 
24, IOP, 594, 603, "i . o . p", "", 
30, NumberPatientsCT, 619, 622, "311", "", "<http://ctro/data#ClinicalTrial_103137> <http://ctro/data#hasNumberPatientsCT> \"311\"."
31, OcularHypertension, 635, 654, "ocular hypertension", "", "<http://ctro/data#ClinicalTrial_103137> <http://ctro/data#analysesHealthCondition> <http://ctro/data#OcularHypertension>."
32, OpenAngleGlaucoma, 658, 679, "open - angle glaucoma", "", "<http://ctro/data#ClinicalTrial_103137> <http://ctro/data#analysesHealthCondition> <http://ctro/data#OpenAngleGlaucoma>."
120, Randomized, 685, 693, "randomly", "", 
33, DoseValue, 722, 723, "2", "", "<http://ctro/data#Medication_103207> <http://ctro/data#hasDoseValue> \"2\"."
35, Percentage, 724, 725, "%", "", "<http://ctro/data#Medication_103207> <http://ctro/data#hasDoseUnit> <http://ctro/data#Percentage>."
37, Dorzolamide, 726, 737, "dorzolamide", "", "<http://ctro/data#Medication_103207> <http://ctro/data#hasDrug> <http://ctro/data#Dorzolamide>."
101434, DeliveryMethod, 751, 760, "topically", "", "<http://ctro/data#DeliveryMethod_103211> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DeliveryMethod>. <http://ctro/data#Medication_103207> <http://ctro/data#hasDeliveryMethod> <http://ctro/data#DeliveryMethod_103211>."
39, Frequency, 761, 764, "TID", "", "<http://ctro/data#Intervention_103189> <http://ctro/data#hasFrequency> \"TID\"."
34, DoseValue, 768, 773, "0 . 5", "", "<http://ctro/data#Medication_103214> <http://ctro/data#hasDoseValue> \"0 . 5\"."
36, Percentage, 774, 775, "%", "", "<http://ctro/data#Medication_103214> <http://ctro/data#hasDoseUnit> <http://ctro/data#Percentage>."
38, Betaxolol, 776, 785, "betaxolol", "", "<http://ctro/data#Medication_103214> <http://ctro/data#hasDrug> <http://ctro/data#Betaxolol>."
101438, DeliveryMethod, 799, 808, "topically", "", "<http://ctro/data#DeliveryMethod_103218> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DeliveryMethod>. <http://ctro/data#Medication_103214> <http://ctro/data#hasDeliveryMethod> <http://ctro/data#DeliveryMethod_103218>."
40, Frequency, 809, 812, "BID", "", "<http://ctro/data#Intervention_103195> <http://ctro/data#hasFrequency> \"BID\"."
41, Placebo, 818, 825, "placebo", "", "<http://ctro/data#Medication_103221> <http://ctro/data#hasDrug> <http://ctro/data#Placebo>."
101439, DeliveryMethod, 839, 848, "topically", "", "<http://ctro/data#DeliveryMethod_103225> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DeliveryMethod>. <http://ctro/data#Medication_103221> <http://ctro/data#hasDeliveryMethod> <http://ctro/data#DeliveryMethod_103225>."
42, Frequency, 849, 851, "QD", "", "<http://ctro/data#Intervention_103201> <http://ctro/data#hasFrequency> \"QD\"."
129, Duration, 856, 864, "12 weeks", "", "<http://ctro/data#ClinicalTrial_103137> <http://ctro/data#hasCTduration> \"12 weeks\"."
132, Precondition, 924, 1009, "patients with IOP > or = 23 mm Hg in at least one eye at 10 AM or 4 PM on study day 1", "", "<http://ctro/data#Population_103158> <http://ctro/data#hasPrecondition> \"patients with IOP > or = 23 mm Hg in at least one eye at 10 AM or 4 PM on study day 1\"."
43, IOP, 938, 941, "IOP", "", 
44, mmHg, 952, 957, "mm Hg", "", 
45, TimePoint, 981, 986, "10 AM", "", 
46, TimePoint, 990, 994, "4 PM", "", 
47, TimePoint, 1004, 1009, "day 1", "", 
133, Randomized, 1015, 1023, "randomly", "", 
49, IOP, 1098, 1101, "IOP", "", 
50, Morning, 1176, 1183, "morning", "", 
57, Peak_IOP, 1184, 1195, "peak effect", "", 
62, TimePoint, 1198, 1204, "hour 2", "", 
56, Trough_IOP, 1221, 1234, "trough effect", "", 
58, TimePoint, 1237, 1243, "hour 8", "", 
51, Duration, 1254, 1262, "12 weeks", "", 
52, Mean, 1280, 1284, "mean", "", 
53, IOP, 1295, 1298, "IOP", "", 
54, Dorzolamide, 1343, 1354, "dorzolamide", "", 
55, Betaxolol, 1359, 1368, "betaxolol", "", 
59, TimePoint, 1389, 1395, "hour 8", "", "<http://ctro/data#Outcome_103228> <http://ctro/data#hasTimePoint> \"hour 8\". <http://ctro/data#Outcome_103255> <http://ctro/data#hasTimePoint> \"hour 8\"."
60, Reduction, 1400, 1405, "3 . 6", "", "<http://ctro/data#Outcome_103228> <http://ctro/data#hasChangeValue> \"3 . 6\". <http://ctro/data#Outcome_103255> <http://ctro/data#hasChangeValue> \"3 . 6\"."
61, mmHg, 1406, 1411, "mm Hg", "", 
63, TimePoint, 1432, 1438, "hour 2", "", "<http://ctro/data#Outcome_103282> <http://ctro/data#hasTimePoint> \"hour 2\". <http://ctro/data#Outcome_103309> <http://ctro/data#hasTimePoint> \"hour 2\"."
64, Reduction, 1443, 1448, "5 . 4", "", "<http://ctro/data#Outcome_103282> <http://ctro/data#hasChangeValue> \"5 . 4\"."
65, Reduction, 1454, 1459, "5 . 3", "", "<http://ctro/data#Outcome_103309> <http://ctro/data#hasChangeValue> \"5 . 3\"."
66, mmHg, 1460, 1465, "mm Hg", "", 
67, Mean, 1574, 1578, "mean", "", "<http://ctro/data#Mean_103168> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean>. <http://ctro/data#Endpoint_103166> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_103168>."
68, IOP, 1579, 1582, "IOP", "", "<http://ctro/data#IOP_103167> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#IOP>. <http://ctro/data#Endpoint_103166> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#IOP_103167>."
69, DiffGroupAbsValue, 1610, 1616, "0 . 02", "", "<http://ctro/data#DiffBetweenGroups_103336> <http://ctro/data#hasDiffGroupAbsValue> \"0 . 02\"."
71, mmHg, 1617, 1622, "mm Hg", "", "<http://ctro/data#Endpoint_103166> <http://ctro/data#hasBaselineUnit> <http://ctro/data#mmHg>."
75, ConfIntervalDiff, 1625, 1645, "- 0 . 870 to 0 . 901", "", "<http://ctro/data#DiffBetweenGroups_103336> <http://ctro/data#hasConfIntervalDiff> \"- 0 . 870 to 0 . 901\"."
73, TimePoint, 1652, 1658, "hour 8", "", 
70, DiffGroupAbsValue, 1663, 1671, "- 0 . 14", "", "<http://ctro/data#DiffBetweenGroups_103345> <http://ctro/data#hasDiffGroupAbsValue> \"- 0 . 14\"."
72, mmHg, 1672, 1677, "mm Hg", "", 
76, ConfIntervalDiff, 1680, 1700, "- 0 . 959 to 0 . 685", "", "<http://ctro/data#DiffBetweenGroups_103345> <http://ctro/data#hasConfIntervalDiff> \"- 0 . 959 to 0 . 685\"."
74, TimePoint, 1707, 1713, "hour 2", "", 
101444, ObservedResult, 1753, 1777, "most frequently reported", "", "<http://ctro/data#Outcome_103379> <http://ctro/data#hasObservedResult> \"most frequently reported\". <http://ctro/data#Outcome_103406> <http://ctro/data#hasObservedResult> \"most frequently reported\"."
101440, EndPointDescription, 1794, 1808, "ocular burning", "", "<http://ctro/data#EndPointDescription_103355> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_103354> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_103355>."
77, Stinging, 1818, 1826, "stinging", "", "<http://ctro/data#Endpoint_103359> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#Stinging>."
101445, ObservedResult, 1833, 1875, "the most frequently reported nonocular AEs", "", "<http://ctro/data#Outcome_103433> <http://ctro/data#hasObservedResult> \"the most frequently reported nonocular AEs\". <http://ctro/data#Outcome_103460> <http://ctro/data#hasObservedResult> \"the most frequently reported nonocular AEs\". <http://ctro/data#Outcome_103487> <http://ctro/data#hasObservedResult> \"the most frequently reported nonocular AEs\". <http://ctro/data#Outcome_103514> <http://ctro/data#hasObservedResult> \"the most frequently reported nonocular AEs\"."
101441, EndPointDescription, 1881, 1897, "taste perversion", "", "<http://ctro/data#EndPointDescription_103370> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_103369> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_103370>."
101442, EndPointDescription, 1900, 1927, "upper respiratory infection", "", "<http://ctro/data#EndPointDescription_103365> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_103364> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_103365>."
158, Headache, 1934, 1942, "headache", "", "<http://ctro/data#Endpoint_103374> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#Headache>."
101443, EndPointDescription, 1967, 1983, "taste perversion", "", 
84, PercentageAffected, 2039, 2045, "14 . 6", "", "<http://ctro/data#Outcome_103460> <http://ctro/data#hasPercentageAffected> \"14 . 6\"."
86, Dorzolamide, 2056, 2067, "dorzolamide", "", 
85, PercentageAffected, 2078, 2083, "0 . 0", "", "<http://ctro/data#Outcome_103514> <http://ctro/data#hasPercentageAffected> \"0 . 0\"."
87, Betaxolol, 2094, 2103, "betaxolol", "", 
88, RelNumPatientsLeftCT, 2114, 2117, "Two", "", "<http://ctro/data#ClinicalTrial_103137> <http://ctro/data#hasRelNumPatientsLeftCT> \"Two\"."
94, ConclusionComment, 2198, 2295, "This study confirmed the similar IOP - lowering effect of 2 % dorzolamide and 0 . 5 % betaxolol .", "", "<http://ctro/data#ClinicalTrial_103137> <http://ctro/data#hasConclusionComment> \"This study confirmed the similar IOP - lowering effect of 2 % dorzolamide and 0 . 5 % betaxolol .\"."
89, IOP, 2231, 2234, "IOP", "", 
90, DoseValue, 2256, 2257, "2", "", 
92, Percentage, 2258, 2259, "%", "", 
168, Dorzolamide, 2260, 2271, "dorzolamide", "", 
91, DoseValue, 2276, 2281, "0 . 5", "", 
93, Percentage, 2282, 2283, "%", "", 
169, Betaxolol, 2284, 2293, "betaxolol", "", 
95, ConclusionComment, 2296, 2384, "Both treatments were generally well tolerated , and their safety profiles were similar .", "", "<http://ctro/data#ClinicalTrial_103137> <http://ctro/data#hasConclusionComment> \"Both treatments were generally well tolerated , and their safety profiles were similar .\"."
96, PMID, 2440, 2447, "9663361", "", "<http://ctro/data#Publication_103126> <http://ctro/data#hasPMID> \"9663361\"."
